XML 57 R42.htm IDEA: XBRL DOCUMENT
v3.24.3

INVESTMENT IN EQUITY SECURITIES (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2024
Equity Method Investments and Joint Ventures [Abstract] |
Schedule of investments in equity securities | Our investment in equity securities consisted of the following:
| September 30, 2024 |  | December 31, 2023
Equity Method Investments: |  |  |
BTY | $ | 33,069 |  |  | $ | 33,090 |
Sonmol | 4,796 |  |  | 4,751 |
Desotec GmbH | 1,000 |  |  | 905 |
Other Investments: |  |  |
PureCycle | 2,768 |  |  | 1,106 |
YAT | 5,414 |  |  | 5,352 |
Loop | 2,894 |  |  | 2,894 |
Others | 1,111 |  |  | 1,105 |
| $ | 51,052 |  |  | $ | 49,203 |
Schedule of sale of PCT shares related to Purecycle investment | We have sold the following PCT shares related to the PureCycle investment:
| Shares Sold |  | Proceeds |  | Realized Gain
2021 | 191,349 |  | $ | 2,434 |  |  | $ | 2,000 |
2022 | 157,600 |  | $ | 1,599 |  |  | $ | 1,213 |
2023 | 510,449 |  | $ | 5,604 |  |  | $ | 4,188 |
Schedule of net investment gain/loss | For the three and nine months ended September 30, 2024 and 2023, we recorded the following net investment gain or loss on our investment in PureCycle:
| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2024 |  | 2023 |  | 2024 |  | 2023
Net investment gain (loss) | $ | 1,043 |  |  | $ | (1,240) |  |  | $ | 1,495 |  |  | $ | 1,839 |

X
- Definition Tabular disclosure of equity method and other investments. + References No definition available. + Details
Name: | atr_EquityMethodAndOtherInvestmentsTableTextBlock
Namespace Prefix: | atr_
Data Type: | dtr-types1:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of financial highlights. Includes, but is not limited to, per share information, income and expense ratios, total return, capital commitment and fee waiver. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 205 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147478494/946-205-50-1 + Details
Name: | us-gaap_InvestmentCompanyFinancialHighlightsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items. + References No definition available. + Details
Name: | us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration